Hardy Reed’s Amgen AMGN Stock Holding History

Hardy Reed’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$240K	Buy	681 +30	+5%	+$10.7K	0.02%	220
2025 Q4	$213K	Buy	+651	New	+$207K	0.02%	228

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Hardy Reed's AMGN Position: Q1 2026 in Review

Hardy Reed increased its Amgen (AMGN) stake by 4.6% in Q1 2026, buying an estimated $10.7K and bringing the position to 681 shares worth $240K. The position accounts for 0.02% of the portfolio, ranked #220.

Hardy Reed first reported a position in AMGN in Q4 2025 and has held it in 2 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Hardy Reed held 681 shares of Amgen worth $240K as of Q1 2026.
Hardy Reed bought 30 Amgen shares in Q1 2026, an estimated $10.7K.
Amgen made up 0.02% of Hardy Reed's portfolio in Q1 2026, its #220 holding.
Hardy Reed first reported a position in Amgen in Q4 2025 and has held it in 2 quarters since.
3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Hardy Reed's 13F filing for Q1 2026, filed 28 Apr 2026.